Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.59459 | 24 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.55898 | 24 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.57544 | 25 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.5231 | 25 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.51561 | 24 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 3.48486 | 55 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.62092 | 25 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.55047 | 24 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.54621 | 25 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.72018 | 32 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.55956 | 25 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.54026 | 24 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.55765 | 24 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.65252 | 29 |